Where options run out, BRIA-ABC bets on survival in metastatic breast cancer
Where options run out, BRIA-ABC bets on survival in metastatic breast cancer Clinical Trials Arena
677 материалов по теме, собраны автоматически из проверенных источников
Where options run out, BRIA-ABC bets on survival in metastatic breast cancer Clinical Trials Arena
Havah Therapeutics Urges FDA to Recognize the Breast Cancer Treatment Potential of Androgen Receptor Activation BioSpace
Havah Therapeutics Urges FDA to Recognize the Breast Cancer Treatment Potential of Androgen Receptor Activation Yahoo Finance
Surviving Breast Cancer is Hard. Providers Are Working to Improve Post-Treatment Care. Rewire News Group
Factors associated with early death from de novo metastatic breast cancer in Ontario, Canada CMAJ | Journal
SystImmune, Inc. to Present New Phase 3 Data on Iza-bren (izalontamab brengitecan) in EGFR-mutated NSCLC, HR+ Breast Cancer, and Phase 2 Data in Head and Neck Cancer at ESMO 2026 Morningstar
Faeth to Present Preclinical Data on PIKTOR in HR+/HER2- Breast Cancer Models at ESMO 2026 Business Wire
У семи кировчанок нашли рак молочной железы Newsler.ru
В Дагестане онкоскрининг на рак груди за три дня прошли 500 женщин Портал Северного Кавказа
Сохраняют жизни: как лечат рак молочной железы у возрастных пациенток Самара 450
Mabwell presents Phase II trial results for breast cancer drug 9MW2821 Vietnam Investment Review - VIR
УЗИ или маммография: маммолог объяснила, как не пропустить рак груди Бел.ру
Рак молочной железы остаётся одним из самых распространённых онкологических заболеваний у женщин Новости Ульяновска. Смотреть онлайн
People who are marginalized or lack access to a primary care provider are at greater risk of early death from newly diagnosed (de novo) metastatic breast cancer, according to research in the Canadian Medical Association Journal.